STAAR Surgical to Report Third Quarter Results on November 1, 2023

Rhea-AI Summary

STAAR Surgical Company to release Q3 2023 financial results and host conference call

LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the third quarter ended September 29, 2023 on Wednesday, November 1, 2023 after the market close.

STAAR will host a conference call and webcast on Wednesday, November 1 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 03857916), please dial 888-259-6580 for domestic participants and 206-962-3782 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com.

A taped replay of the conference call (Replay Code 857916) will be available beginning approximately one hour after the call’s conclusion for seven days. This replay can be accessed by dialing 877-674-7070 for domestic callers and 416-764-8692 for international callers. An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™ product line. More than 2,500,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231018623693/en/

Investors & Media

Brian Moore

Vice President, Investor, Media Relations and Corporate Development

(626) 303-7902, Ext. 3023

bmoore@staar.com

Source: STAAR Surgical Company

FAQ

When will STAAR Surgical Company release its Q3 2023 financial results?

STAAR Surgical Company will release its Q3 2023 financial results on Wednesday, November 1, 2023.

What time will the conference call and webcast discussing the financial results be held?

The conference call and webcast will be held on Wednesday, November 1 at 4:30 p.m. Eastern / 1:30 p.m. Pacific.

How can I access the conference call?

To access the conference call, please dial 888-259-6580 for domestic participants and 206-962-3782 for international participants.

Where can I access the live webcast?

The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com.

Will there be a replay of the conference call available?

Yes, a taped replay of the conference call will be available for seven days. It can be accessed by dialing 877-674-7070 for domestic callers and 416-764-8692 for international callers.

Will there be an archived webcast available?

Yes, an archived webcast will be available at www.staar.com.